应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
XFOR X4制药
盘后交易 02-24 18:18:38 EST
0.4538
-0.0133
-2.85%
盘后
0.4600
+0.0062
+1.37%
18:12 EST
最高
0.4900
最低
0.4419
成交量
94.62万
今开
0.4900
昨收
0.4671
日振幅
10.30%
总市值
7,739万
流通市值
5,819万
总股本
1.71亿
成交额
43.44万
换手率
0.74%
流通股本
1.28亿
市净率
1.30
ROE
-26.35%
每股收益
-0.09
52周最高
1.60
52周最低
0.2612
市盈率
-5.28
股息
0.00
股息收益率
0.00
ROA
-46.55%
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
X4制药盘中异动 大幅下跌5.14%
市场透视 · 14:55
X4制药盘中异动 大幅下跌5.14%
X4制药盘中异动 早盘股价大涨6.78%报0.543美元
市场透视 · 02-18
X4制药盘中异动 早盘股价大涨6.78%报0.543美元
X4制药盘中异动 股价大涨5.20%报0.506美元
市场透视 · 02-13
X4制药盘中异动 股价大涨5.20%报0.506美元
X4制药盘中异动 股价大跌5.77%报0.480美元
市场透视 · 02-11
X4制药盘中异动 股价大跌5.77%报0.480美元
X4制药盘中异动 急速下挫5.16%
市场透视 · 02-10
X4制药盘中异动 急速下挫5.16%
X4制药股价重挫18.82% 市值跌1607.42万美元
市场透视 · 02-06
X4制药股价重挫18.82% 市值跌1607.42万美元
X4制药盘中异动 早盘股价大涨5.25%报0.627美元
市场透视 · 02-05
X4制药盘中异动 早盘股价大涨5.25%报0.627美元
X4制药盘中异动 急速下挫7.35%
市场透视 · 02-04
X4制药盘中异动 急速下挫7.35%
X4制药盘中异动 早盘快速下挫9.50%报0.634美元
市场透视 · 02-03
X4制药盘中异动 早盘快速下挫9.50%报0.634美元
X4制药盘中异动 早盘股价大涨7.45%
市场透视 · 01-30
X4制药盘中异动 早盘股价大涨7.45%
X4制药盘中异动 下午盘股价大涨7.93%
市场透视 · 01-29
X4制药盘中异动 下午盘股价大涨7.93%
X4制药盘中异动 早盘股价大跌5.76%
市场透视 · 01-27
X4制药盘中异动 早盘股价大跌5.76%
X4制药盘中异动 早盘股价大跌5.16%
市场透视 · 01-24
X4制药盘中异动 早盘股价大跌5.16%
X4制药盘中异动 股价大涨5.31%报0.514美元
市场透视 · 01-23
X4制药盘中异动 股价大涨5.31%报0.514美元
X4制药盘中异动 股价大跌5.04%
市场透视 · 01-21
X4制药盘中异动 股价大跌5.04%
X4制药盘中异动 股价大涨5.33%报0.486美元
市场透视 · 01-17
X4制药盘中异动 股价大涨5.33%报0.486美元
X4制药盘中异动 股价大涨5.31%报0.480美元
市场透视 · 01-15
X4制药盘中异动 股价大涨5.31%报0.480美元
X4制药盘中异动 早盘快速上涨5.23%
市场透视 · 01-13
X4制药盘中异动 早盘快速上涨5.23%
X4制药盘中异动 早盘快速下挫5.23%
市场透视 · 01-10
X4制药盘中异动 早盘快速下挫5.23%
X4制药盘中异动 临近收盘股价大跌5.14%
市场透视 · 01-07
X4制药盘中异动 临近收盘股价大跌5.14%
加载更多
公司概况
公司名称:
X4制药
所属市场:
NASDAQ
上市日期:
2017-11-16
主营业务:
X4 Pharmaceuticals, Inc.于2010年8月2日根据特拉华州法律注册成立。该公司是一家晚期临床阶段的生物制药公司,发现和开发用于治疗罕见疾病和治疗选择有限的疾病的新疗法,重点关注免疫系统功能障碍导致的疾病。该公司的主要临床候选药物是mavorixafor,这是一种趋化因子受体CXCR4的小分子选择性拮抗剂,正在开发为一种口服、每日一次的疗法。由于mavorixafor能够增加成熟、功能性白细胞进入血液的动员,该公司认为mavorixafor有可能在多种慢性中性粒细胞减少症中提供治疗益处,包括WHIM(疣、低丙种球蛋白血症、感染和骨髓松弛症)综合征,这是一种罕见的原发性免疫缺陷。
发行价格:
--
{"stockData":{"symbol":"XFOR","market":"US","secType":"STK","nameCN":"X4制药","latestPrice":0.4538,"timestamp":1740430800000,"preClose":0.4671,"halted":0,"volume":946176,"hourTrading":{"tag":"盘后","latestPrice":0.46,"preClose":0.4538,"latestTime":"18:12 EST","volume":35478,"amount":16015.41773784,"timestamp":1740438742936},"delay":0,"floatShares":128235476,"shares":170546469,"eps":-0.085969,"marketStatus":"盘后交易","change":-0.0133,"latestTime":"02-24 18:18:35 EST","open":0.49,"high":0.49,"low":0.4419,"amount":434440.61810688,"amplitude":0.102976,"askPrice":0.4993,"askSize":100,"bidPrice":0.4457,"bidSize":7000,"shortable":3,"etf":0,"ttmEps":-0.085969,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1740445200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1510808400000,"exchange":"NASDAQ","adjPreClose":0.4671,"preHourTrading":{"tag":"盘前","latestPrice":0.4936,"preClose":0.4671,"latestTime":"09:18 EST","volume":2654,"amount":1250.37684372,"timestamp":1740406735957},"postHourTrading":{"tag":"盘后","latestPrice":0.46,"preClose":0.4538,"latestTime":"18:12 EST","volume":35478,"amount":16015.41773784,"timestamp":1740438742936},"volumeRatio":0.771663,"impliedVol":0.462,"impliedVolPercentile":0.016},"requestUrl":"/m/hq/s/XFOR","defaultTab":"news","newsList":[{"id":"2513442720","title":"X4制药盘中异动 大幅下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513442720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513442720?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:55","pubTimestamp":1740408942,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时55分,X4制药股票出现波动,股价快速跳水5.14%。截至发稿,该股报0.443美元/股,成交量22.5575万股,换手率0.13%,振幅9.21%。机构评级方面,在所有5家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中,整体涨幅为0.12%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225542962e9ee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225542962e9ee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2512165772","title":"X4制药盘中异动 早盘股价大涨6.78%报0.543美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165772?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:43","pubTimestamp":1739889784,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时43分,X4制药股票出现波动,股价大幅拉升6.78%。截至发稿,该股报0.543美元/股,成交量16.9739万股,换手率0.10%,振幅5.37%。最近的财报数据显示,该股实现营业收入560000.00美元,净利润-36.70百万美元,每股收益-0.18美元,毛利253000.00美元,市盈率-6.79倍。X4制药股票所在的生物技术行业中,整体涨幅为0.60%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224304abd3b1da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224304abd3b1da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2511578121","title":"X4制药盘中异动 股价大涨5.20%报0.506美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511578121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511578121?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:16","pubTimestamp":1739467003,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日01时16分,X4制药股票出现波动,股价急速拉升5.20%。截至发稿,该股报0.506美元/股,成交量44.3566万股,换手率0.26%,振幅4.72%。最近的财报数据显示,该股实现营业收入560000.00美元,净利润-36.70百万美元,每股收益-0.18美元,毛利253000.00美元,市盈率-6.25倍。X4制药股票所在的生物技术行业中,整体涨幅为0.89%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021401164498844c68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021401164498844c68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2510338706","title":"X4制药盘中异动 股价大跌5.77%报0.480美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510338706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510338706?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:58","pubTimestamp":1739285903,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时58分,X4制药股票出现波动,股价急速跳水5.77%。截至发稿,该股报0.480美元/股,成交量30.8376万股,换手率0.18%,振幅6.26%。最近的财报数据显示,该股实现营业收入560000.00美元,净利润-36.70百万美元,每股收益-0.18美元,毛利253000.00美元,市盈率-6.15倍。X4制药股票所在的生物技术行业中,整体跌幅为1.34%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112258249881c263&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112258249881c263&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2510699068","title":"X4制药盘中异动 急速下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510699068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510699068?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:22","pubTimestamp":1739200940,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时22分,X4制药股票出现异动,股价急速下挫5.16%。截至发稿,该股报0.502美元/股,成交量37.739万股,换手率0.22%,振幅5.04%。机构评级方面,在所有5家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中,整体跌幅为0.18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102322209880832a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102322209880832a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2509272764","title":"X4制药股价重挫18.82% 市值跌1607.42万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509272764?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:31","pubTimestamp":1738852265,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时31分,X4制药股票出现波动,股价大幅下跌18.82%。截至发稿,该股报0.501美元/股,成交量178.147万股,换手率1.04%,振幅0.53%。机构评级方面,在所有5家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中,整体跌幅为0.12%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223105abc4d410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223105abc4d410&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2509580238","title":"X4制药盘中异动 早盘股价大涨5.25%报0.627美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509580238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509580238?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:24","pubTimestamp":1738769059,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时24分,X4制药股票出现异动,股价大幅拉升5.25%。截至发稿,该股报0.627美元/股,成交量41.4124万股,换手率0.24%,振幅7.60%。最近的财报数据显示,该股实现营业收入560000.00美元,净利润-36.70百万美元,每股收益-0.18美元,毛利253000.00美元,市盈率-7.82倍。X4制药股票所在的生物技术行业中,整体涨幅为1.35%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232419a23a8775&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232419a23a8775&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2508717457","title":"X4制药盘中异动 急速下挫7.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508717457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508717457?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:35","pubTimestamp":1738679701,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时35分,X4制药股票出现波动,股价大幅下挫7.35%。截至发稿,该股报0.556美元/股,成交量61.7287万股,换手率0.36%,振幅4.08%。X4制药股票所在的生物技术行业中,整体跌幅为0.02%。X4制药公司简介:X4 Pharmaceuticals Inc 是一家后期临床生物制药公司,致力于研究和开发治疗罕见疾病和治疗选择有限的疾病的新型疗法,重点关注由免疫系统功能障碍引起的疾病。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223501abc228fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223501abc228fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2508144694","title":"X4制药盘中异动 早盘快速下挫9.50%报0.634美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508144694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508144694?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593310,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分,X4制药股票出现波动,股价快速跳水9.50%。截至发稿,该股报0.634美元/股,成交量82.5147万股,换手率0.48%,振幅5.57%。机构评级方面,在所有5家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中,整体跌幅为0.36%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223510abc107e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223510abc107e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2507621239","title":"X4制药盘中异动 早盘股价大涨7.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507621239?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:31","pubTimestamp":1738247507,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时31分,X4制药股票出现波动,股价大幅拉升7.45%。截至发稿,该股报0.790美元/股,成交量1915.19万股,换手率11.23%,振幅3.29%。X4制药股票所在的生物技术行业中,整体涨幅为0.22%。X4制药公司简介:X4 Pharmaceuticals Inc 是一家后期临床生物制药公司,致力于研究和开发治疗罕见疾病和治疗选择有限的疾病的新型疗法,重点关注由免疫系统功能障碍引起的疾病。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223147a2345503&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223147a2345503&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2507650513","title":"X4制药盘中异动 下午盘股价大涨7.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507650513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507650513?lang=zh_cn&edition=full","pubTime":"2025-01-30 03:48","pubTimestamp":1738180125,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日03时48分,X4制药股票出现波动,股价大幅拉升7.93%。截至发稿,该股报0.520美元/股,成交量74.3719万股,换手率0.44%,振幅12.22%。机构评级方面,在所有5家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中,整体涨幅为1.48%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130034846a2339bad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130034846a2339bad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2506269303","title":"X4制药盘中异动 早盘股价大跌5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506269303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506269303?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:31","pubTimestamp":1737988313,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时31分,X4制药股票出现异动,股价大幅跳水5.76%。截至发稿,该股报0.450美元/股,成交量30.4885万股,换手率0.18%,振幅4.19%。X4制药股票所在的生物技术行业中,整体涨幅为0.01%。X4制药公司简介:X4 Pharmaceuticals Inc 是一家后期临床生物制药公司,致力于研究和开发治疗罕见疾病和治疗选择有限的疾病的新型疗法,重点关注由免疫系统功能障碍引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223154a2316ac3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223154a2316ac3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2505861949","title":"X4制药盘中异动 早盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505861949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505861949?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:54","pubTimestamp":1737730442,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时54分,X4制药股票出现异动,股价快速下跌5.16%。截至发稿,该股报0.491美元/股,成交量83.3096万股,换手率0.49%,振幅6.70%。机构评级方面,在所有5家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中,整体跌幅为0.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124225402960f91e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124225402960f91e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2505501723","title":"X4制药盘中异动 股价大涨5.31%报0.514美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505501723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505501723?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:22","pubTimestamp":1737645768,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时22分,X4制药股票出现异动,股价快速上涨5.31%。截至发稿,该股报0.514美元/股,成交量17.3433万股,换手率0.10%,振幅5.08%。机构评级方面,在所有5家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中,整体跌幅为0.32%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123232249a22d1488&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123232249a22d1488&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2505827740","title":"X4制药盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505827740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505827740?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:50","pubTimestamp":1737471035,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时50分,X4制药股票出现波动,股价大幅下跌5.04%。截至发稿,该股报0.482美元/股,成交量21.805万股,换手率0.13%,振幅4.28%。机构评级方面,在所有5家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中,整体涨幅为1.15%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225035a22a5ba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225035a22a5ba0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2504900162","title":"X4制药盘中异动 股价大涨5.33%报0.486美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504900162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504900162?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:57","pubTimestamp":1737125836,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时57分,X4制药股票出现波动,股价大幅上涨5.33%。截至发稿,该股报0.486美元/股,成交量9.6523万股,换手率0.06%,振幅4.08%。最近的财报数据显示,该股实现营业收入560000.00美元,净利润-36.70百万美元,每股收益-0.18美元,毛利253000.00美元,市盈率-5.97倍。X4制药股票所在的生物技术行业中,整体涨幅为0.55%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117225716abaeb651&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117225716abaeb651&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2503187625","title":"X4制药盘中异动 股价大涨5.31%报0.480美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503187625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503187625?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:02","pubTimestamp":1736953342,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时02分,X4制药股票出现波动,股价大幅上涨5.31%。截至发稿,该股报0.480美元/股,成交量43.1383万股,换手率0.25%,振幅3.97%。机构评级方面,在所有5家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中,整体涨幅为1.16%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115230222ababf9e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115230222ababf9e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2503588252","title":"X4制药盘中异动 早盘快速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503588252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503588252?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778684,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分,X4制药股票出现波动,股价大幅拉升5.23%。截至发稿,该股报0.600美元/股,成交量610.912万股,换手率3.58%,振幅0.00%。机构评级方面,在所有5家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中,整体跌幅为1.01%。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223125a2203e9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223125a2203e9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2502895096","title":"X4制药盘中异动 早盘快速下挫5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502895096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502895096?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:03","pubTimestamp":1736521391,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时03分,X4制药股票出现异动,股价大幅下跌5.23%。截至发稿,该股报0.603美元/股,成交量38.7183万股,换手率0.23%,振幅7.04%。X4制药股票所在的生物技术行业中,整体跌幅为1.06%。X4制药公司简介:X4 Pharmaceuticals Inc 是一家后期临床生物制药公司,致力于研究和开发治疗罕见疾病和治疗选择有限的疾病的新型疗法,重点关注由免疫系统功能障碍引起的疾病。它还拥有两个临床前候选药物X4P-003和X4P-002,它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023031195ff755a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023031195ff755a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2501573796","title":"X4制药盘中异动 临近收盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501573796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501573796?lang=zh_cn&edition=full","pubTime":"2025-01-08 04:31","pubTimestamp":1736281876,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日04时31分,X4制药股票出现波动,股价大幅下挫5.14%。截至发稿,该股报0.702美元/股,成交量90.3864万股,换手率0.53%,振幅9.16%。机构评级方面,在所有5家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。X4制药股票所在的生物技术行业中,整体涨幅为0.92%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108043116a2192fdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108043116a2192fdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.x4pharma.com","stockEarnings":[{"period":"1week","weight":-0.0814},{"period":"1month","weight":-0.0426},{"period":"3month","weight":0.382},{"period":"6month","weight":-0.3772},{"period":"1year","weight":-0.4848},{"period":"ytd","weight":-0.3633}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0074},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.1821},{"period":"ytd","weight":0.0236}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"X4 Pharmaceuticals, Inc.于2010年8月2日根据特拉华州法律注册成立。该公司是一家晚期临床阶段的生物制药公司,发现和开发用于治疗罕见疾病和治疗选择有限的疾病的新疗法,重点关注免疫系统功能障碍导致的疾病。该公司的主要临床候选药物是mavorixafor,这是一种趋化因子受体CXCR4的小分子选择性拮抗剂,正在开发为一种口服、每日一次的疗法。由于mavorixafor能够增加成熟、功能性白细胞进入血液的动员,该公司认为mavorixafor有可能在多种慢性中性粒细胞减少症中提供治疗益处,包括WHIM(疣、低丙种球蛋白血症、感染和骨髓松弛症)综合征,这是一种罕见的原发性免疫缺陷。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.002706},{"month":2,"riseRate":0.625,"avgChangeRate":0.030119},{"month":3,"riseRate":0.571429,"avgChangeRate":0.137927},{"month":4,"riseRate":0.285714,"avgChangeRate":0.026234},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.016456},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.244326},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.029016},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.090685},{"month":9,"riseRate":0.285714,"avgChangeRate":0.011165},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.121911},{"month":11,"riseRate":0.285714,"avgChangeRate":0.198505},{"month":12,"riseRate":0.375,"avgChangeRate":-0.068572}],"exchange":"NASDAQ","name":"X4制药","nameEN":"X4 Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.2","shortVersion":"4.31.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供X4制药(XFOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"X4制药,XFOR,X4制药股票,X4制药股票老虎,X4制药股票老虎国际,X4制药行情,X4制药股票行情,X4制药股价,X4制药股市,X4制药股票价格,X4制药股票交易,X4制药股票购买,X4制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供X4制药(XFOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}